Inogen, Inc. (INGN)
- Previous Close
7.06 - Open
7.16 - Bid 5.08 x 200
- Ask 9.21 x 200
- Day's Range
7.14 - 7.22 - 52 Week Range
6.40 - 13.33 - Volume
3,824 - Avg. Volume
329,932 - Market Cap (intraday)
193.991M - Beta (5Y Monthly) 1.49
- PE Ratio (TTM)
-- - EPS (TTM)
-1.52 - Earnings Date May 7, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
10.00
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
www.inogen.comRecent News: INGN
View MorePerformance Overview: INGN
Trailing total returns as of 5/2/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: INGN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: INGN
View MoreValuation Measures
Market Cap
189.82M
Enterprise Value
95.43M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.50
Price/Book (mrq)
1.09
Enterprise Value/Revenue
0.28
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-10.69%
Return on Assets (ttm)
-7.78%
Return on Equity (ttm)
-18.95%
Revenue (ttm)
335.7M
Net Income Avi to Common (ttm)
-35.89M
Diluted EPS (ttm)
-1.52
Balance Sheet and Cash Flow
Total Cash (mrq)
113.8M
Total Debt/Equity (mrq)
11.16%
Levered Free Cash Flow (ttm)
-928.5k